The National Oesophago-Gastric Cancer Audit (NOGCA) evaluates the quality of care for patients with oesophago-gastric (OG) cancer in England and Wales.

It looks at three types of cancer that occur in:

• The oesophagus – the tube that connects the mouth to the stomach
• The gastro-oesophageal junction (GOJ) – the point where the oesophagus joins the stomach
• The stomach – the organ that helps to digest swallowed food

(Cancers of the oesophagus or GOJ are often referred to as oesophageal cancer).

The audit provides information that enables NHS cancer services to compare their performance and to identify areas of care that could be improved. Since 2012, the audit has also included patients with high grade dysplasia (HGD) of the oesophagus, which is a condition that increases a person’s risk of developing cancer.

In December 2021, the audit published its 13th annual report  which focuses on patients diagnosed with OG cancer or oesophageal HGD between April 2018 and March 2020, the majority of whom received or started their treatment before the COVID-19 pandemic began in early 2020.

A summary report has recently been published, aimed at patients, family members and carers to highlight key findings from the annual report, including links to relevant sections of the annual report.